Antiarrhythmic Drugs in Elderly and Frail Patients

CurrentCurrents epidemiologic scenarios show a progressive increase in worldwide population and life expectancy due to advancements in technological and pharmaceutical tools for diagnosing and treating patients (Divo in Eur Respir J 44:1055–1068, 2014; Newman in The Epidemiology of Aging, 2012) [1, 2]. This increase is strictly linked to the parallel rise in the mean age of the population and, more importantly, in the proportion of old and very old subjects (Newman in The Epidemiology of Aging, 2012) [2].